Immune homeostasis requires several biologic factors including glucocorticoid hormones

被引:15
作者
Cancedda, C [1 ]
Filaci, G [1 ]
Puppo, F [1 ]
Ghio, M [1 ]
Contini, P [1 ]
Indiveri, F [1 ]
机构
[1] Univ Genoa, Dept Internal Med, Div Clin Immunol, I-16132 Genoa, Italy
来源
NEUROENDOCRINE IMMUNE BASIS OF THE RHEUMATIC DISEASES II, PROCEEDINGS | 2002年 / 966卷
关键词
immunological activity; T cells; corticosteroids; soluble Fas ligand; hormones;
D O I
10.1111/j.1749-6632.2002.tb04201.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Immunological tolerance can be achieved by several mechanisms including suppressor cells, soluble factors, and neurohormonal mediators. On the cellular level, we isolated a population of CD8+CD28- T cells capable of inhibiting anti-CD3 mAb-induced proliferation of autologous peripheral blood mononuclear cells in an HLA-I nonrestricted manner via production of IFN-gamma and IL-6. Interestingly, CD8+CD28- T cells from systemic lupus erythematosus patients with active disease do not display this inhibitory activity and show a marked imbalance between inhibitory (IL-6) and stimulatory (IL-12) cytokines. For soluble factors, we studied soluble HLA molecules (sHLAs) and double-stranded DNA (ds-DNA). Soluble HLA-I (sHLA-I) molecules induce soluble Fas ligand (sFasL) secretion and trigger apoptosis in phytohemagglutin (PHA)-activated Fas+ T cells. Double-stranded DNA binds to HLA-II molecules and inhibits HLA-II-mediated antigen presentation. On the neurohormonal side, we focused our attention on the immunological activity of corticosteroids (CTSs). CTSs inhibit recirculation of CD4+ T cells, suppress the proliferation and immunological function of activated T cells, and induce apoptosis of activated lymphocytes. Taken together, these data suggest the presence of a complex network of immunoregulatory mechanisms in which CTSs play a strong role supporting their recognized efficacy in the treatment of inflammatory and immunological diseases.
引用
收藏
页码:49 / 63
页数:15
相关论文
共 25 条
[1]  
ALLISON JP, 1977, J IMMUNOL, V118, P1004
[2]   IMMUNOSUPPRESSION BY GLUCOCORTICOIDS - INHIBITION OF NF-KAPPA-B ACTIVITY THROUGH INDUCTION OF I-KAPPA-B SYNTHESIS [J].
AUPHAN, N ;
DIDONATO, JA ;
ROSETTE, C ;
HELMBERG, A ;
KARIN, M .
SCIENCE, 1995, 270 (5234) :286-290
[3]   GLUCOCORTICOSTEROID THERAPY - MECHANISMS OF ACTION AND CLINICAL CONSIDERATIONS [J].
FAUCI, AS ;
DALE, DC ;
BALOW, JE .
ANNALS OF INTERNAL MEDICINE, 1976, 84 (03) :304-315
[4]  
Filaci G, 1998, EUR J IMMUNOL, V28, P3968
[5]   Impairment of CD8+ T suppressor cell function in patients with active systemic lupus erythematosus [J].
Filaci, G ;
Bacilieri, S ;
Fravega, M ;
Monetti, M ;
Contini, P ;
Ghio, M ;
Setti, M ;
Puppo, F ;
Indiveri, F .
JOURNAL OF IMMUNOLOGY, 2001, 166 (10) :6452-6457
[6]   CIRCULATING DNA AND LUPUS NEPHRITIS [J].
FOURNIE, GJ .
KIDNEY INTERNATIONAL, 1988, 33 (02) :487-497
[7]   Soluble HLA class I and Fas ligand molecules in blood components and their role in the immunomodulatory effects of blood transfusions [J].
Ghio, M ;
Contini, P ;
Mazzei, C ;
Brenci, S ;
Filaci, G ;
Indiveri, F ;
Puppo, F .
LEUKEMIA & LYMPHOMA, 2000, 39 (1-2) :29-36
[8]   DEFLAZACORT IN THE TREATMENT OF HEMATOLOGIC DISORDERS [J].
GOBBI, M ;
SCUDELETTI, M .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1993, 45 :S25-S28
[9]   CIRCADIAN VARIATIONS OF AUTOLOGOUS MIXED LYMPHOCYTE REACTIONS AND ENDOGENOUS CORTISOL [J].
INDIVERI, F ;
PIERRI, I ;
ROGNA, S ;
POGGI, A ;
MONTALDO, P ;
ROMANO, R ;
PENDE, A ;
MORGANO, A ;
BARABINO, A ;
FERRONE, S .
JOURNAL OF IMMUNOLOGICAL METHODS, 1985, 82 (01) :17-24
[10]   VARIOUS MODES OF GENE-REGULATION BY NUCLEAR RECEPTORS FOR STEROID AND THYROID-HORMONES [J].
KARIN, M ;
YANGYEN, HF ;
CHAMBARD, JC ;
DENG, T ;
SAATCIOGLU, F .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1993, 45 :S9-S15